Title: The latest contraceptive option: The single-rod implant.

POPLINE Document Number: 314814

Author(s):

Creinin MD
Clark B

Source citation:

Contemporary Ob / Gyn, 2005 Sep;50(9):54-57.

Abstract:

A reversible, highly effective, and long-acting contraceptive is expected to become available soon to women in the United States. Once approved by the Food and Drug Administration, Implanon will be the only contraceptive implant available in this country. It will give women seeking long-acting reversible contraception a new option in addition to the levonorgestrel intrauterine system, the Copper-T IUD, and the depot medroxyprogesterone acetate quarterly injection. Already being used in Australia, Indonesia, the Netherlands, and at least 30 other countries, this single-rod implant has proven to be safe and highly effective. It provides continuous efficacy for up to 3 years, can be quickly inserted and removed, provides constant hormone levels, and does not affect bone mineral density. Furthermore, the new implant can be used during lactation and may even improve dysmenorrhea and acne. Yet, like most progestin contraceptives, it can cause side effects, particularly irregular vaginal bleeding. (excerpt)

Keywords:

United States
Progress Report
Clinical Research
Women
Contraceptive Implants
Contraceptive Safety
Contraceptive Effectiveness
Time Factors
Osteoporosis
Contraceptive Agents, Progestin
Dysmenorrhea
Acne
North America
Americas
Developed Countries
Research Methodology
Demographic Factors
Population
Contraceptive Methods
Contraception
Family Planning
Safety
Public Health
Health
Population Dynamics
Skeletal Effects
Physiology
Biology
Contraceptive Agents, Female
Contraceptive Agents
Menstruation Disorders
Diseases
Dermatitis